Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rigaku Americas Corporation is a leading provider of analytical X-ray instrumentation and services, serving the life sciences, pharmaceutical, and materials science industries. The company specializes in advanced technologies for protein crystallography, small molecule X-ray diffraction, and small-angle X-ray scattering (SAXS), which are essential for structural biology and drug discovery workflows. Their product portfolio includes high-brightness X-ray generators, automated crystallization systems, and sophisticated detectors designed to accelerate the characterization of complex biological molecules. Beyond hardware, Rigaku provides comprehensive software solutions and maintenance services to support researchers in academic and industrial laboratories worldwide. Headquartered in The Woodlands, Texas, it operates as the primary North and South American subsidiary of the global Rigaku Corporation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rigaku Americas.